Edition:
United States

Jianmin Pharmaceutical Group Co Ltd (600976.SS)

600976.SS on Shanghai Stock Exchange

21.48CNY
25 Jun 2018
Change (% chg)

¥-0.02 (-0.09%)
Prev Close
¥21.50
Open
¥21.51
Day's High
¥21.89
Day's Low
¥21.33
Volume
447,400
Avg. Vol
808,513
52-wk High
¥29.69
52-wk Low
¥18.96

Summary

Name Age Since Current Position

Qin He

56 Chairman of the Board

Qinqiang Liu

52 2009 President, Director

Hongyun He

44 2012 Chief Financial Officer

Zhenbo Hu

43 Vice President, Secretary of the Board

Fuliang Xiong

46 Vice President

Guizhi Sun

56 Chief Engineer

Rong Pei

42 2011 Director

Siyang Wang

26 2011 Director

Qingsheng Zhang

52 2011 Director

Xian Lin

58 2011 Independent Director

Pengfei Tu

50 2011 Independent Director

Jinguo Xin

50 2013 Independent Director

Biographies

Name Description

Qin He

Mr. He Qin is Chairman of the Board in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. He is also Chairman of the Board in Kunming Pharmaceutical Corp. and two other companies, as well as Vice President in another pharmaceutical company. He used to serve as Chairman of the Board, General Manager, Vice President and Director in other companies.

Qinqiang Liu

Mr. Liu Qinqiang has been President and Director in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. He used to serve as General Manager and Chairman of the Board in Wuhan Zhonglian Pharmaceutical Group Co., Ltd., as well as Deputy Head of Factory and Head of Factory in a Wuhan-based pharmaceutical factory.

Hongyun He

Mr. He Hongyun has been Chief Financial Officer in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. since September 20, 2012. He used to be Head of Funds and Finance Department in a group company, Head of Finance Management in China National Aviation Holding Company, Deputy General Manager of Finance and Auditing China Department/Investment Supervision Department in China National Aviation Holding Company (Hong Kong), as well as Senior Financial Manager in Air China. He holds a Master's degree in Economics. He is Certified Public Accountant.

Zhenbo Hu

Mr. Hu Zhenbo has been Vice President, Secretary of the Board in Wuhan Jianmin Pharmaceutical Group Co., Ltd. He is also Chairman of the Board in a Wuhan-based company.

Fuliang Xiong

Mr. Xiong Fuliang is Vice President in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. He used to serve as Director of Research Institute of the Company.

Guizhi Sun

Ms. Sun Guizhi is Chief Engineer in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. She used to be Head of Quality Assurance and Head of Technology Development of the Company.

Rong Pei

Ms. Pei Rong is Director in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. She is also Chief Operation Officer and Director in a group company, as well as Director in Kunming Pharmaceutical Corp. and another pharmaceutical company.

Siyang Wang

Mr. Wang Siyang is Director in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. He is also Director in Kunming Pharmaceutical Corp., as well as Assistant President in a group company.

Qingsheng Zhang

Mr. Zhang Qingsheng has been serving as Director in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. since August 9, 2011. He is also serving as Deputy General Manager and Secretary of the Board in CHINA TRADITIONAL & HERBAL MEDICINE GROUP CO. LIMITED, where he used to be Director.

Xian Lin

Mr. Lin Xian has been serving as Independent Director in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. since August 9, 2011. He is also serving as Independent Director in Shanghai Kaichuan Marine International Co., Ltd. and another company.

Pengfei Tu

Mr. Tu Pengfei has been serving as Independent Director in Wuhan Jianmin Pharmaceutical Groups Co., Ltd. since August 9, 2011. He is Professor in Peking University, China. He is also Independent Director of Kunming Pharmaceutical Corp.

Jinguo Xin

Basic Compensation

Name Fiscal Year Total

Qin He

--

Qinqiang Liu

--

Hongyun He

100,000

Zhenbo Hu

--

Fuliang Xiong

400,000

Guizhi Sun

350,000

Rong Pei

--

Siyang Wang

--

Qingsheng Zhang

--

Xian Lin

90,000

Pengfei Tu

90,000

Jinguo Xin

--
As Of  30 Dec 2012